May 13, 2024 5:02 PM
Updated Jun 2, 2025 6:52 PM
haleon plc faced a short-seller attack from marshall wace, which has built a position around £150 million, its first major challenge since spinning off from gsk and pfizer two years ago.
Haleon PLC (LSE:HLN), known for its Sensodyne and Advil products, is currently dealing with a significant short-seller attack from Marshall Wace, which has taken a position worth around £150 million.
It marks the company's first major short-seller challenge since its spinoff from GSK and Pfizer two years ago.
Despite the reports, the stock remained relatively stable closing Monday at 328.4p, up 0.18%.
Comments
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy